Institute of Medicine of the National Academies Meeting 3: Public Health Effectiveness of the FDA 510(k) Clearance Process

Institute of Medicine of the National Academies
Meeting 3: Public Health Effectiveness of the FDA 510(k) Clearance Process

July 28, 2010

Buy Ativan USA

Now Playing: Welcome and Opening Remarks
David Challoner, Chair, IOM Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process

WEBCAST ARCHIVES

WEBCAST SPONSORS

WEBCAST POWERED BY